CAV2 and infection: Intravenously-delivered CAV2 may enter astrocytes preferentially via exosomes delivered across endothelial cells, while direct injection of CAV2 into the brain parenchyma may result in direct infection of cells without the formation of exosomes, which could potentially explain this difference.